Amanda Barkley-Levenson has accepted a post-doc position and will join the Palmer Lab in Spring 2015! She is currently finishing her PhD in John Crabbe’s lab at the Oregon Health & Sciences University. Her dissertation is titled “The role of neuropeptide Y in binge-like drinking in mice”.
A recent article by Francie Diep in Scientific American explores the National Institute of Health’s new initiative that encourages researchers to design sex-balanced experiments. Part of this policy includes additional funding opportunities that add more animals to existing studies, in order to balance the sexes. Dr. Palmer received one of these supplementary grants in June to double the number of mice being used and allow for statistically-strong sex-specific results. Read the full article here!
The University of Chicago’s student-run newspaper, The Chicago Maroon, recently highlighted Dr. Palmer’s work for the new NIDA National Center of Excellence for GWAS in Outbred Rats. The Center seeks to use rats to investigate the genetic basis of drug abuse and other related behaviors. You can read the full article here!
Biotechnology company Illumina recently profiled Dr. Abraham Palmer for their October 2014 iCommunity newsletter. The interview highlights the Palmer lab’s work to elucidate the genetic basis of psychiatric and behavioral traits, with a particular focus on how they’ve utilized Illumina’s cutting-edge sequencing and genomic technologies to do so. Read the entire piece here and learn more about Illumina’s products here!
A recent article by Jeremy Allen of the Michigan Live focuses on the exciting research being done by Terry Robinson and Shelly Flagel of the University of Michigan as part of the new national Center of Excellence for GWAS in Outbred Rats (led by Abraham Palmer, University of Chicago).
Both labs were awarded a five-year, $1.5 million grant to study addiction-related behaviors in rats. Their project is titled “Genetic Studies of Incentive Salience” and is one of four initial projects supported by the Center. They will investigate the genetic basis of
Kevin Jiang of Science Life recently highlighted the research being done at the new NIDA National Center for Excellence for GWAS in Outbred Rats, which is led by Dr. Abraham Palmer. Dr. Palmer elaborated on the goals of the center as well as the benefits of using rats to specifically study drug abuse-related behaviors. You can read the full article here!
Dr. Palmer presented at the Genetics, Bioinformatics, and Systems Biology Colloquium at the University of California – San Diego last week, hosted by Jonathan Sebat, Department of Psychiatry and Institute for Genetic Medicine. His talk was titled “Using quantitative genetic studies to understand the brain”.
In an article by Roni Caryn Rabin of the New York Times, Dr. Palmer recently discussed the drawbacks of single-sex studies as well as the important role of sex-specific genetic differences in drug abuse and other complex traits. You can read the full article here!
This article is part of the media interest into the NIH’s new funding initiative to combat gender biases in preclinical and clinical research. Dr. Palmer recently received a NIDA R01 Supplement (“Administrative Supplement for Research on Sex/Gender Differences”) in order to explore sex differences in genes that
The first of many annual retreats for the NIDA National Center of Excellence for Genome-wide Association Studies in Outbred Rats (P50DA037844) was held on September 17th! Collaborators from across the nation gathered on the University of Chicago campus to meet one another, discuss the goals of the center, and brainstorm for upcoming projects.
The NIDA National Center of Excellence was founded in 2014 to utilize cutting-edge genetic methods to elucidate the genetics of drug abuse-related behaviors in rats. The P50 grant is titled “Integrated GWAS of complex behavioral and gene expression
